LAP3 and Alzheimer disease: In conclusion, canine CDS is presented as a useful experimental model for AD, which could be relevant to the development of screening tools for determining risk within a given population in order to apply therapeutic strategies for Aβ-related neurodegenerative diseases, in which NEP appears as a key peptidase.